Redcliffe Hygiene Private Limited announced that the company received INR 248 million co-led by new investors, Rainmatter and NATCO Pharma Limited on September 12, 2023. The transaction also included participation from returning investor, Alkemi Growth Capital LLP.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
990 INR | +1.59% | -2.57% | +22.01% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.01% | 2.09B | |
+30.71% | 682B | |
+30.35% | 586B | |
-3.47% | 364B | |
+18.13% | 327B | |
+4.00% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.10% | 165B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Redcliffe Hygiene Private Limited announced that it has received INR 248 million in funding from Rainmatter, Alkemi Growth Capital LLP, NATCO Pharma Limited